The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Repeat Expansion Disorders Treatment Market Research Report 2025

Global Repeat Expansion Disorders Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1725683

No of Pages : 96

Ask Your Query

Synopsis
The global Repeat Expansion Disorders Treatment market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Repeat Expansion Disorders Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Repeat Expansion Disorders Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Highlights

The global market for Repeat Expansion Disorders Treatment in Hospital Pharmacies is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Repeat Expansion Disorders Treatment include Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics, Capsida Biotherapeutics Inc., Larimar Therapeutics, Inc., Healx, Intellia Therapeutics, Inc., Editas Medicine, Bluebird bio, Inc. and Sanofi, Merck & Co., Inc., etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Oral, which accounted for % of the global market of Repeat Expansion Disorders Treatment in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Repeat Expansion Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Repeat Expansion Disorders Treatment.
The Repeat Expansion Disorders Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Repeat Expansion Disorders Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Repeat Expansion Disorders Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

  • Pfizer, Inc.
  • CRISPR Therapeutics
  • Acorda Therapeutics
  • Capsida Biotherapeutics Inc.
  • Larimar Therapeutics, Inc.
  • Healx, Intellia Therapeutics, Inc.
  • Editas Medicine
  • Bluebird bio, Inc.
  • Sanofi, Merck & Co., Inc.
  • H. Lundbeck A/S
  • Cellectis SA
  • Bio-Techne
  • GlaxoSmithKline plc
  • Allergan Aurobindo Pharma Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Cipla Ltd

Product Type Insights
Global markets are presented by Repeat Expansion Disorders Treatment type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Repeat Expansion Disorders Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Repeat Expansion Disorders Treatment segment by Type

  • Oral
  • Injection

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Repeat Expansion Disorders Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Repeat Expansion Disorders Treatment market.
Repeat Expansion Disorders Treatment Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Repeat Expansion Disorders Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Repeat Expansion Disorders Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Repeat Expansion Disorders Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Repeat Expansion Disorders Treatment industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Repeat Expansion Disorders Treatment.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Repeat Expansion Disorders Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Repeat Expansion Disorders Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Repeat Expansion Disorders Treatment Market Perspective (2017-2028)
2.2 Repeat Expansion Disorders Treatment Growth Trends by Region
2.2.1 Repeat Expansion Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Repeat Expansion Disorders Treatment Historic Market Size by Region (2017-2022)
2.2.3 Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2023-2028)
2.3 Repeat Expansion Disorders Treatment Market Dynamics
2.3.1 Repeat Expansion Disorders Treatment Industry Trends
2.3.2 Repeat Expansion Disorders Treatment Market Drivers
2.3.3 Repeat Expansion Disorders Treatment Market Challenges
2.3.4 Repeat Expansion Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue
3.1.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue (2017-2022)
3.1.2 Global Repeat Expansion Disorders Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Repeat Expansion Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Repeat Expansion Disorders Treatment Revenue
3.4 Global Repeat Expansion Disorders Treatment Market Concentration Ratio
3.4.1 Global Repeat Expansion Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Repeat Expansion Disorders Treatment Revenue in 2021
3.5 Repeat Expansion Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Repeat Expansion Disorders Treatment Product Solution and Service
3.7 Date of Enter into Repeat Expansion Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Repeat Expansion Disorders Treatment Breakdown Data by Type
4.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Type (2017-2022)
4.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2023-2028)
5 Repeat Expansion Disorders Treatment Breakdown Data by Application
5.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Application (2017-2022)
5.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Repeat Expansion Disorders Treatment Market Size (2017-2028)
6.2 North America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
6.3 North America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Repeat Expansion Disorders Treatment Market Size (2017-2028)
7.2 Europe Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
7.3 Europe Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Repeat Expansion Disorders Treatment Market Size (2017-2028)
8.2 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Repeat Expansion Disorders Treatment Market Size (2017-2028)
9.2 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
9.3 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Repeat Expansion Disorders Treatment Market Size (2017-2028)
10.2 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Repeat Expansion Disorders Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.1.5 Pfizer, Inc. Recent Development
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Detail
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics Repeat Expansion Disorders Treatment Introduction
11.2.4 CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.2.5 CRISPR Therapeutics Recent Development
11.3 Acorda Therapeutics
11.3.1 Acorda Therapeutics Company Detail
11.3.2 Acorda Therapeutics Business Overview
11.3.3 Acorda Therapeutics Repeat Expansion Disorders Treatment Introduction
11.3.4 Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.3.5 Acorda Therapeutics Recent Development
11.4 Capsida Biotherapeutics Inc.
11.4.1 Capsida Biotherapeutics Inc. Company Detail
11.4.2 Capsida Biotherapeutics Inc. Business Overview
11.4.3 Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Introduction
11.4.4 Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.4.5 Capsida Biotherapeutics Inc. Recent Development
11.5 Larimar Therapeutics, Inc.
11.5.1 Larimar Therapeutics, Inc. Company Detail
11.5.2 Larimar Therapeutics, Inc. Business Overview
11.5.3 Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction
11.5.4 Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.5.5 Larimar Therapeutics, Inc. Recent Development
11.6 Healx, Intellia Therapeutics, Inc.
11.6.1 Healx, Intellia Therapeutics, Inc. Company Detail
11.6.2 Healx, Intellia Therapeutics, Inc. Business Overview
11.6.3 Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction
11.6.4 Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.6.5 Healx, Intellia Therapeutics, Inc. Recent Development
11.7 Editas Medicine
11.7.1 Editas Medicine Company Detail
11.7.2 Editas Medicine Business Overview
11.7.3 Editas Medicine Repeat Expansion Disorders Treatment Introduction
11.7.4 Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.7.5 Editas Medicine Recent Development
11.8 Bluebird bio, Inc.
11.8.1 Bluebird bio, Inc. Company Detail
11.8.2 Bluebird bio, Inc. Business Overview
11.8.3 Bluebird bio, Inc. Repeat Expansion Disorders Treatment Introduction
11.8.4 Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.8.5 Bluebird bio, Inc. Recent Development
11.9 Sanofi, Merck & Co., Inc.
11.9.1 Sanofi, Merck & Co., Inc. Company Detail
11.9.2 Sanofi, Merck & Co., Inc. Business Overview
11.9.3 Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Introduction
11.9.4 Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.9.5 Sanofi, Merck & Co., Inc. Recent Development
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Company Detail
11.10.2 H. Lundbeck A/S Business Overview
11.10.3 H. Lundbeck A/S Repeat Expansion Disorders Treatment Introduction
11.10.4 H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.10.5 H. Lundbeck A/S Recent Development
11.11 Cellectis SA
11.11.1 Cellectis SA Company Detail
11.11.2 Cellectis SA Business Overview
11.11.3 Cellectis SA Repeat Expansion Disorders Treatment Introduction
11.11.4 Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.11.5 Cellectis SA Recent Development
11.12 Bio-Techne
11.12.1 Bio-Techne Company Detail
11.12.2 Bio-Techne Business Overview
11.12.3 Bio-Techne Repeat Expansion Disorders Treatment Introduction
11.12.4 Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.12.5 Bio-Techne Recent Development
11.13 GlaxoSmithKline plc
11.13.1 GlaxoSmithKline plc Company Detail
11.13.2 GlaxoSmithKline plc Business Overview
11.13.3 GlaxoSmithKline plc Repeat Expansion Disorders Treatment Introduction
11.13.4 GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.13.5 GlaxoSmithKline plc Recent Development
11.14 Allergan Aurobindo Pharma Ltd.
11.14.1 Allergan Aurobindo Pharma Ltd. Company Detail
11.14.2 Allergan Aurobindo Pharma Ltd. Business Overview
11.14.3 Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Introduction
11.14.4 Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.14.5 Allergan Aurobindo Pharma Ltd. Recent Development
11.15 Sun Pharmaceutical Industries Ltd.
11.15.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.15.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.15.3 Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Introduction
11.15.4 Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.15.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.16 Torrent Pharmaceuticals Ltd.
11.16.1 Torrent Pharmaceuticals Ltd. Company Detail
11.16.2 Torrent Pharmaceuticals Ltd. Business Overview
11.16.3 Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction
11.16.4 Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.16.5 Torrent Pharmaceuticals Ltd. Recent Development
11.17 Intas Pharmaceuticals Ltd.
11.17.1 Intas Pharmaceuticals Ltd. Company Detail
11.17.2 Intas Pharmaceuticals Ltd. Business Overview
11.17.3 Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction
11.17.4 Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.17.5 Intas Pharmaceuticals Ltd. Recent Development
11.18 Cipla Ltd
11.18.1 Cipla Ltd Company Detail
11.18.2 Cipla Ltd Business Overview
11.18.3 Cipla Ltd Repeat Expansion Disorders Treatment Introduction
11.18.4 Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.18.5 Cipla Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Repeat Expansion Disorders Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Repeat Expansion Disorders Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Repeat Expansion Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Repeat Expansion Disorders Treatment Market Share by Region (2017-2022)
Table 8. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Repeat Expansion Disorders Treatment Market Share by Region (2023-2028)
Table 10. Repeat Expansion Disorders Treatment Market Trends
Table 11. Repeat Expansion Disorders Treatment Market Drivers
Table 12. Repeat Expansion Disorders Treatment Market Challenges
Table 13. Repeat Expansion Disorders Treatment Market Restraints
Table 14. Global Repeat Expansion Disorders Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Repeat Expansion Disorders Treatment Market Share by Players (2017-2022)
Table 16. Global Top Repeat Expansion Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2021)
Table 17. Ranking of Global Top Repeat Expansion Disorders Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Repeat Expansion Disorders Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Repeat Expansion Disorders Treatment Product Solution and Service
Table 21. Date of Enter into Repeat Expansion Disorders Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Repeat Expansion Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Repeat Expansion Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Repeat Expansion Disorders Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Repeat Expansion Disorders Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer, Inc. Company Detail
Table 42. Pfizer, Inc. Business Overview
Table 43. Pfizer, Inc. Repeat Expansion Disorders Treatment Product
Table 44. Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 45. Pfizer, Inc. Recent Development
Table 46. CRISPR Therapeutics Company Detail
Table 47. CRISPR Therapeutics Business Overview
Table 48. CRISPR Therapeutics Repeat Expansion Disorders Treatment Product
Table 49. CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 50. CRISPR Therapeutics Recent Development
Table 51. Acorda Therapeutics Company Detail
Table 52. Acorda Therapeutics Business Overview
Table 53. Acorda Therapeutics Repeat Expansion Disorders Treatment Product
Table 54. Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 55. Acorda Therapeutics Recent Development
Table 56. Capsida Biotherapeutics Inc. Company Detail
Table 57. Capsida Biotherapeutics Inc. Business Overview
Table 58. Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Product
Table 59. Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 60. Capsida Biotherapeutics Inc. Recent Development
Table 61. Larimar Therapeutics, Inc. Company Detail
Table 62. Larimar Therapeutics, Inc. Business Overview
Table 63. Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Product
Table 64. Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 65. Larimar Therapeutics, Inc. Recent Development
Table 66. Healx, Intellia Therapeutics, Inc. Company Detail
Table 67. Healx, Intellia Therapeutics, Inc. Business Overview
Table 68. Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Product
Table 69. Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 70. Healx, Intellia Therapeutics, Inc. Recent Development
Table 71. Editas Medicine Company Detail
Table 72. Editas Medicine Business Overview
Table 73. Editas Medicine Repeat Expansion Disorders Treatment Product
Table 74. Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 75. Editas Medicine Recent Development
Table 76. Bluebird bio, Inc. Company Detail
Table 77. Bluebird bio, Inc. Business Overview
Table 78. Bluebird bio, Inc. Repeat Expansion Disorders Treatment Product
Table 79. Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 80. Bluebird bio, Inc. Recent Development
Table 81. Sanofi, Merck & Co., Inc. Company Detail
Table 82. Sanofi, Merck & Co., Inc. Business Overview
Table 83. Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Product
Table 84. Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 85. Sanofi, Merck & Co., Inc. Recent Development
Table 86. H. Lundbeck A/S Company Detail
Table 87. H. Lundbeck A/S Business Overview
Table 88. H. Lundbeck A/S Repeat Expansion Disorders Treatment Product
Table 89. H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 90. H. Lundbeck A/S Recent Development
Table 91. Cellectis SA Company Detail
Table 92. Cellectis SA Business Overview
Table 93. Cellectis SA Repeat Expansion Disorders TreatmentProduct
Table 94. Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 95. Cellectis SA Recent Development
Table 96. Bio-Techne Company Detail
Table 97. Bio-Techne Business Overview
Table 98. Bio-Techne Repeat Expansion Disorders TreatmentProduct
Table 99. Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 100. Bio-Techne Recent Development
Table 101. GlaxoSmithKline plc Company Detail
Table 102. GlaxoSmithKline plc Business Overview
Table 103. GlaxoSmithKline plc Repeat Expansion Disorders TreatmentProduct
Table 104. GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 105. GlaxoSmithKline plc Recent Development
Table 106. Allergan Aurobindo Pharma Ltd. Company Detail
Table 107. Allergan Aurobindo Pharma Ltd. Business Overview
Table 108. Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders TreatmentProduct
Table 109. Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 110. Allergan Aurobindo Pharma Ltd. Recent Development
Table 111. Sun Pharmaceutical Industries Ltd. Company Detail
Table 112. Sun Pharmaceutical Industries Ltd. Business Overview
Table 113. Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders TreatmentProduct
Table 114. Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 115. Sun Pharmaceutical Industries Ltd. Recent Development
Table 116. Torrent Pharmaceuticals Ltd. Company Detail
Table 117. Torrent Pharmaceuticals Ltd. Business Overview
Table 118. Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders TreatmentProduct
Table 119. Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 120. Torrent Pharmaceuticals Ltd. Recent Development
Table 121. Intas Pharmaceuticals Ltd. Company Detail
Table 122. Intas Pharmaceuticals Ltd. Business Overview
Table 123. Intas Pharmaceuticals Ltd. Repeat Expansion Disorders TreatmentProduct
Table 124. Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 125. Intas Pharmaceuticals Ltd. Recent Development
Table 126. Cipla Ltd Company Detail
Table 127. Cipla Ltd Business Overview
Table 128. Cipla Ltd Repeat Expansion Disorders TreatmentProduct
Table 129. Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 130. Cipla Ltd Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Repeat Expansion Disorders Treatment Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Repeat Expansion Disorders Treatment Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Repeat Expansion Disorders Treatment Report Years Considered
Figure 9. Global Repeat Expansion Disorders Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Repeat Expansion Disorders Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Repeat Expansion Disorders Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Repeat Expansion Disorders Treatment Market Share by Players in 2021
Figure 13. Global Top Repeat Expansion Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Repeat Expansion Disorders Treatment Revenue in 2021
Figure 15. North America Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Repeat Expansion Disorders Treatment Market Share by Country (2017-2028)
Figure 17. United States Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Repeat Expansion Disorders Treatment Market Share by Country (2017-2028)
Figure 21. Germany Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Repeat Expansion Disorders Treatment Market Share by Region (2017-2028)
Figure 29. China Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Repeat Expansion Disorders Treatment Market Share by Country (2017-2028)
Figure 37. Mexico Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Repeat Expansion Disorders Treatment Market Share by Country (2017-2028)
Figure 41. Turkey Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Pfizer, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 44. CRISPR Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 45. Acorda Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 46. Capsida Biotherapeutics Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 47. Larimar Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 48. Healx, Intellia Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 49. Editas Medicine Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 50. Bluebird bio, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 51. Sanofi, Merck & Co., Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 52. H. Lundbeck A/S Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 53. Cellectis SA Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 54. Bio-Techne Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 55. GlaxoSmithKline plc Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 56. Allergan Aurobindo Pharma Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 57. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 58. Torrent Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 59. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 60. Cipla Ltd Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock